August 27, 2021 at 08:40PM CEPROTIN

Product approval information is indicated for patients with Severe Congenital Protein C Deficiency for the prevention and treatment of venous thrombosis and purpura fulminans.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3znHwPq